Skip to main content

Table 5 Sensitivity analysis (in US$) based on screening of 1000 suspects, comparing AFB smear plus Culture, and AFB smear plus PCR dot-blot

From: Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosis

   

Cost per accurately diagnosed

case of TB

Cost per case accurately diagnosed

and treated, including treatment of

falsely diagnosed cases

Cost per case incorrectly diagnosed

and not treated**

Component

Current

situation

Adjustment

AFB smear

plus Culture

AFB

smear plus

PCR

dot-blot

Ratio

AFB smear

plus Culture

AFB

smear

plus

PCR

dot-blot

Ratio

AFB smear

plus Culture

AFB smear

plus PCR

dot-blot

Ratio

TB prevalence

46%

No adjustment

50,773

13,749

3.7

55,501

15,190

3.6

22,045,767,

5,836,887

3.8

  

10%

233,554

63,246

3.7

255,304

69,874

3.6

124,926,015

27,725,214

4.5

  

20%

116,777

31,623

3.7

127,652

34,937

3.6

20,821,002

$

3,960,745

5.3

  

40%

58,389

15,812

3.7

63,826

17,469

3.6

9,609,693

1,980,372

4.9

  

60%

38,926

10,541

3.7

42,551

11,646

3.6

505,773

94,303

5.4

Sensitivity

PCR dot-blot

85%

95%

46,577

12,386

3.7

50,914

13,683

3.7

3,097,339

916,536

3.4

Specificity

PCR dot-blot

85%

95%

39,688

10,554

3.7

43,384

11,659

3.7

2,639,282

780,992

3.4

PCR dot-blot

running costs*

12,833

10,000

50,772

13,723

3.7

55,501

15,164

3.7

20,045,767

5,825,852

3.8

  1. * assuming that PCR dot-blot running costs could be decreased by 22%, ** assuming that one false negative transmits TB to 10 individuals and these 5% have TB and the cost-effectiveness was expressed for 1000 suspects.